In an experimental study of crescentic glomerulonephritis, the administration of anti-TNF-α monoclonal antibody reduced glomerular inflammation, crescent formation, and tubulointerstitial scarring with preservation of renal function [77]. The gene discussed is TNF; the disease is crescentic glomerulonephritis.